Literature DB >> 18241240

Empiric refinement of the pathologic assessment of Lewy-related pathology in the dementia patient.

James B Leverenz1, Ronald Hamilton, Debby W Tsuang, Aimee Schantz, Darcy Vavrek, Eric B Larson, Walter A Kukull, Oscar Lopez, Douglas Galasko, Eliezer Masliah, Jeffrey Kaye, Randall Woltjer, Christopher Clark, John Q Trojanowski, Thomas J Montine.   

Abstract

Lewy-related pathology (LRP) is a common pathologic finding at autopsy in dementia patients. Recently criteria for categorizing types of LRP in dementia patients were published, though these criteria have yet to be systematically applied to large dementia samples. We examined a large (n = 208) referral-based autopsy sample for LRP, and applied the published criteria for LRP categorization to these cases. We found almost half (49%) of LRP positive cases from this sample were not classifiable. However, modifying the published criteria by reducing the number of regions requiring examination, allowing more variability in LRP severity scores within specific brain regions, and adding an amygdala predominant category permitted classification of 97% of LRP positive cases from the referral-based sample. Application of the modified criteria to an unrelated community-based autopsy sample (n = 226) allowed classification of 96% of LRP positive cases. Modest modifications in the published criteria permit a significantly greater number of dementia cases with LRP to be classified. In addition, this modification allows for more limited sampling of brain regions for classification of LRP. We propose that these modified criteria for the categorization of LRP be utilized in patients with a history of dementia.

Entities:  

Mesh:

Year:  2008        PMID: 18241240      PMCID: PMC2689097          DOI: 10.1111/j.1750-3639.2007.00117.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  21 in total

Review 1.  Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages).

Authors:  Heiko Braak; Kelly Del Tredici; Hansjürgen Bratzke; John Hamm-Clement; Daniele Sandmann-Keil; Udo Rüb
Journal:  J Neurol       Date:  2002-10       Impact factor: 4.849

2.  Staging of brain pathology related to sporadic Parkinson's disease.

Authors:  Heiko Braak; Kelly Del Tredici; Udo Rüb; Rob A I de Vos; Ernst N H Jansen Steur; Eva Braak
Journal:  Neurobiol Aging       Date:  2003 Mar-Apr       Impact factor: 4.673

3.  Pathological entity of dementia with Lewy bodies and its differentiation from Alzheimer's disease.

Authors:  Wami Marui; Eizo Iseki; Masanori Kato; Hiroyasu Akatsu; Kenji Kosaka
Journal:  Acta Neuropathol       Date:  2004-05-14       Impact factor: 17.088

4.  Epitope mapping of LB509, a monoclonal antibody directed against human alpha-synuclein.

Authors:  R Jakes; R A Crowther; V M Lee; J Q Trojanowski; T Iwatsubo; M Goedert
Journal:  Neurosci Lett       Date:  1999-07-02       Impact factor: 3.046

5.  Progression and staging of Lewy pathology in brains from patients with dementia with Lewy bodies.

Authors:  Wami Marui; Eizo Iseki; Toshiki Nakai; Satoshi Miura; Masanori Kato; Kenji Uéda; Kenji Kosaka
Journal:  J Neurol Sci       Date:  2002-03-30       Impact factor: 3.181

Review 6.  Stanley Fahn Lecture 2005: The staging procedure for the inclusion body pathology associated with sporadic Parkinson's disease reconsidered.

Authors:  Heiko Braak; Jürgen R Bohl; Christian M Müller; Udo Rüb; Rob A I de Vos; Kelly Del Tredici
Journal:  Mov Disord       Date:  2006-12       Impact factor: 10.338

7.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

8.  Regional distribution of alpha-synuclein pathology in unimpaired aging and Alzheimer disease.

Authors:  Laura Parkkinen; Hilkka Soininen; Irina Alafuzoff
Journal:  J Neuropathol Exp Neurol       Date:  2003-04       Impact factor: 3.685

9.  Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies.

Authors:  A R Merdes; L A Hansen; D V Jeste; D Galasko; C R Hofstetter; G J Ho; L J Thal; J Corey-Bloom
Journal:  Neurology       Date:  2003-05-27       Impact factor: 9.910

10.  Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases.

Authors:  John E Duda; Benoit I Giasson; Meghann E Mabon; Virginia M-Y Lee; John Q Trojanowski
Journal:  Ann Neurol       Date:  2002-08       Impact factor: 10.422

View more
  57 in total

1.  Neocortical and hippocampal amyloid-β and tau measures associate with dementia in the oldest-old.

Authors:  John L Robinson; Felix Geser; Maria M Corrada; Daniel J Berlau; Steven E Arnold; Virginia M-Y Lee; Claudia H Kawas; John Q Trojanowski
Journal:  Brain       Date:  2011-11-26       Impact factor: 13.501

2.  National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease.

Authors:  Bradley T Hyman; Creighton H Phelps; Thomas G Beach; Eileen H Bigio; Nigel J Cairns; Maria C Carrillo; Dennis W Dickson; Charles Duyckaerts; Matthew P Frosch; Eliezer Masliah; Suzanne S Mirra; Peter T Nelson; Julie A Schneider; Dietmar Rudolf Thal; Bill Thies; John Q Trojanowski; Harry V Vinters; Thomas J Montine
Journal:  Alzheimers Dement       Date:  2012-01       Impact factor: 21.566

Review 3.  The Lewy body in Parkinson's disease and related neurodegenerative disorders.

Authors:  Koichi Wakabayashi; Kunikazu Tanji; Saori Odagiri; Yasuo Miki; Fumiaki Mori; Hitoshi Takahashi
Journal:  Mol Neurobiol       Date:  2012-05-24       Impact factor: 5.590

4.  Alzheimer's disease phenotypes and genotypes associated with mutations in presenilin 2.

Authors:  Suman Jayadev; James B Leverenz; Ellen Steinbart; Justin Stahl; William Klunk; Cheng-En Yu; Thomas D Bird
Journal:  Brain       Date:  2010-04       Impact factor: 13.501

Review 5.  Pathologic correlates of dementia in individuals with Lewy body disease.

Authors:  Joshua A Sonnen; Nadia Postupna; Eric B Larson; Paul K Crane; Shannon E Rose; Kathleen S Montine; James B Leverenz; Thomas J Montine
Journal:  Brain Pathol       Date:  2010-05       Impact factor: 6.508

6.  Pathological α-synuclein distribution in subjects with coincident Alzheimer's and Lewy body pathology.

Authors:  Jon B Toledo; Pallavi Gopal; Kevin Raible; David J Irwin; Johannes Brettschneider; Samantha Sedor; Kayla Waits; Susana Boluda; Murray Grossman; Vivianna M Van Deerlin; Edward B Lee; Steven E Arnold; John E Duda; Howard Hurtig; Virginia M-Y Lee; Charles H Adler; Thomas G Beach; John Q Trojanowski
Journal:  Acta Neuropathol       Date:  2015-12-31       Impact factor: 17.088

7.  Incidental Lewy body disease: do some cases represent a preclinical stage of dementia with Lewy bodies?

Authors:  Roberta Frigerio; Hiroshige Fujishiro; Tae-Beom Ahn; Keith A Josephs; Demetrius M Maraganore; Anthony DelleDonne; Joseph E Parisi; Kevin J Klos; Bradley F Boeve; Dennis W Dickson; J Eric Ahlskog
Journal:  Neurobiol Aging       Date:  2009-06-26       Impact factor: 4.673

8.  Ecology of the aging human brain.

Authors:  Joshua A Sonnen; Karen Santa Cruz; Laura S Hemmy; Randall Woltjer; James B Leverenz; Kathleen S Montine; Clifford R Jack; Jeffrey Kaye; Kelvin Lim; Eric B Larson; Lon White; Thomas J Montine
Journal:  Arch Neurol       Date:  2011-08

9.  GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology.

Authors:  Debby Tsuang; James B Leverenz; Oscar L Lopez; Ronald L Hamilton; David A Bennett; Julie A Schneider; Aron S Buchman; Eric B Larson; Paul K Crane; Jeffrey A Kaye; Patricia Kramer; Randy Woltjer; Walter Kukull; Peter T Nelson; Gregory A Jicha; Janna H Neltner; Doug Galasko; Eliezer Masliah; John Q Trojanowski; Gerard D Schellenberg; Dora Yearout; Haley Huston; Allison Fritts-Penniman; Ignacio F Mata; Jia Y Wan; Karen L Edwards; Thomas J Montine; Cyrus P Zabetian
Journal:  Neurology       Date:  2012-10-03       Impact factor: 9.910

10.  APOE DNA methylation is altered in Lewy body dementia.

Authors:  Jessica Tulloch; Lesley Leong; Sunny Chen; C Dirk Keene; Steven P Millard; Andrew Shutes-David; Oscar L Lopez; Julia Kofler; Jeffrey A Kaye; Randy Woltjer; Peter T Nelson; Janna H Neltner; Gregory A Jicha; Douglas Galasko; Eliezer Masliah; James B Leverenz; Chang-En Yu; Debby Tsuang
Journal:  Alzheimers Dement       Date:  2018-03-12       Impact factor: 21.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.